Esperion Therapeutics, Inc.·4

Oct 20, 4:12 PM ET

Looker Benjamin 4

4 · Esperion Therapeutics, Inc. · Filed Oct 20, 2025

Insider Transaction Report

Form 4
Period: 2025-10-17
Looker Benjamin
Chief Legal Officer
Transactions
  • Sale

    Common Stock

    2025-10-17$2.62/sh1,248$3,275392,422 total
Footnotes (1)
  • [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.

Documents

2 files